Clinical Trial Update: A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetics of a single 14 mg teriflunomide tablet in healthy Chinese volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED